New Study On Companion Diagnostics and Personalized Medicine Market Report 2012 By MarketResearchReports
New Market Research Report Added In MarketResearchReports.Biz Database Companion Diagnostics and Personalized Medicine Market Report 2012.
- (1888PressRelease) March 12, 2013 - This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace.Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population-the field of stratified medicine.
To Buy The Copy Of This Report Visit: http://www.marketresearchreports.biz/analysis-details/companion-diagnostics-and-personalized-medicine-market-report-2012.
Companion Diagnostics has been rapidly expanding over the past 3 years and in this market report we describe the current state of the marketplace from the following perspectives:
- All the Prognostic and Predictive Biomarkers with Potential Clinical Utility are described-a few have already been developed into CDx and we expect growth in this space
- Targeted Therapeutics, Associated Biomarkers, Therapeutic Indications, and Testing Mandates are Described
- Companion Diagnostics Partnerships and Collaborations from 2009 to 2012 are Presented-Provides an Up-to-Date State of the Industry Describing the Disease Areas being Addressed and Types of Biomarkers Being Deployed
- Quantitative Market Metrics
- Quantitative Market Forecast: Market Sizing and Growth Rate
- Revenue Breakout: Rx versus Dx
- Targeted Rx and CDx Pricing
- Publication Hotspot Analyses of the Various Cancer Biomarker Classes for Identifying Niches of Market Opportunity in Various Disease Classes.
This data-driven characterization of the Companion Diagnostics and Personalized Medicine field is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development-all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling "drag-and-drop" into business presentations/business plans-this Market Report is written and delivered to customers in PowerPoint format.
Extensive Market Analyses Presented in this Report
To Read The Complete Report with TOC Kindly Visit: http://www.marketresearchreports.biz/analysis/132398
Personalized Medicine and Companion Diagnostics: Market Segmentation and Quantitative Analysis
- Prognostic Biomarkers in Cancer Listing, Description, and Clinical Significance
- Predictive Biomarkers in Cancer Listing, Description, and Clinical Significance
- Summary of Pathways to Regulatory Approval of Companion Diagnostics
- LDTs under CLIA Certification
- Outcomes with Drugs in Various Disease Classes
- Percent of Tumor Classes where Tumors are Associated with Characterized Somatic Mutations
- Companion Diagnostics and Personalized Medicine: Quantitative Market Metrics
- How Much Does it Cost to Develop a Companion Diagnostic?
- Precedent for Premium Pricing in Cancer Targeted Therapeutics
- Pricing of Selected Personalized Medicine Tests
- Growth of the Personalized Medicine Marketplace: Market Size/Forecast and Growth Rate
Personalized Medicine Industry Landscape: Selected Indications, Biomarkers and Therapeutics
To Buy The Copy Of This Report Visit: http://www.marketresearchreports.biz/analysis-details/companion-diagnostics-and-personalized-medicine-market-report-2012
Market Trends and Evolution of the CDx Marketplace
- Disparities between Rx and CDx Companies
- Varying Economic Incentives between Rx and Dx Development
- Increasing Targeted Rx in the Oncology Space and Effect on CDx Development
- Current Rx/CDx Co-development Programs in Phase III Trials with Listing of Associated Biomarkers
- Cancer Classes Addressable by CDx
- Characterization of Molecular Biomarker Classes: Hotspot Analysis of Publications
- Cancer Biomarkers
- Oncogenes
- Tumor Suppressor Genes
- Non-coding RNAs
Collaborations and Partnering in the CDx Space
- 2012
- 2011
- 2010
- 2009
For More Information Contact:
Hemendra Parmar
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
sales ( @ ) marketResearchReports dot biz
website: http://www.marketresearchreports.biz/
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam